NCT01716702

Brief Summary

Background: Prostate cancer (PCa) is the most common cancer for men. When treated early enough it is typically curable. However, common treatments, such as radical prostatectomy and radiation therapy, often result in significant negative outcomes with regard to sexual, psychological and social function. Both men and partners have identified the need for more information and support to address sexual health concerns after treatment. However, very few sexual rehabilitation interventions have been developed and rigorously assessed. Purpose: The investigators propose to develop and pilot test a new program to meet the sexual health needs of men with PCa and their partners using an online, professionally facilitated education/support program. The goals of the program are to improve sexual function, intimacy and mood for men and their partners after treatment for localized PCa. The program will be offered through Cancer Chat Canada, an existing and well-tested Canadian platform for professionally facilitated support group programs. What Participants Can Expect: A total of 24 men and their female partners (48 individuals) will be recruited and assigned to one of two groups. The first group will participate in the program immediately; the second group will be offered the program after a 5-month delay. The decision about which group will start immediately and which later will be made randomly (by chance). Both groups of men and partners will be asked to complete questionnaires three times and, at the end of the program, to provide the researchers feedback about how satisfied they were with the program, the changes they made, things they learned as a result of the program, and suggestions for improving the program. Participants must have access to a computer, an Internet connection and be willing to attend online, chat room meetings each week for 1.5 hours for 6 weeks. Implications: Sexual rehabilitation is a high need for men affected by PCa, but is difficult to access. The investigators hope to improve access to sexual health care through this study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable prostate-cancer

Timeline
Completed

Started Jul 2012

Typical duration for not_applicable prostate-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 9, 2012

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

October 16, 2012

Completed
14 days until next milestone

First Posted

Study publicly available on registry

October 30, 2012

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2016

Completed
Last Updated

August 21, 2024

Status Verified

March 1, 2014

Enrollment Period

4.3 years

First QC Date

October 16, 2012

Last Update Submit

August 19, 2024

Conditions

Keywords

Prostate CancerPsychosocial InterventionSexual RehabilitationOnline Intervention

Outcome Measures

Primary Outcomes (1)

  • Change in Sexual Function from Baseline to 13 weeks

    Pre-Intervention (Week 1); Post-Intervention (Week 7); 3 Months Post-Intervention (Week 13)

Secondary Outcomes (1)

  • Change in Personal Assessment of Intimacy and Relationships from baseline to 13 weeks

    Pre-Intervention (Week 1); Post-Intervention (Week 7); 3 Months Post-Intervention (Week 13)

Other Outcomes (1)

  • Change in Profile of Mood States Short Form from baseline to 13 weeks

    Pre-Intervention (Week 1); Post-Intervention (Week 7); 3 Months Post-Intervention (Week 13)

Study Arms (2)

Couples Prostate Cancer Support Group

EXPERIMENTAL

The participants in the support group will receive 6 weekly online intervention sessions with a professional facilitator. In addition participants will be asked to complete relationship-enhancement exercises and readings in between sessions. Participants will be asked to complete questionnaires at three time points: 1)pre-intervention (baseline) 2) post-intervention (7 weeks), and 3) post intervention (13 weeks).

Behavioral: Couples Prostate Cancer Support Group

Wait-List Control

NO INTERVENTION

Participants will be asked to complete questionnaires at three time points: 1)week 1 2) week 7, and 3) week 13.

Interventions

The participants in the experimental group will receive 6 weekly online intervention sessions with a professional facilitator. In addition participants will be asked to complete relationship-enhancement exercises and readings in between sessions. In the experimental group, participants will be asked to complete questionnaires at three time points: 1)pre-intervention (baseline) 2) post-intervention (7 weeks), and 3) post intervention (13 weeks). In the waitlist group, participants will not participate in the support group. Participants will be asked to complete questionnaires at three time points: 1)pre-intervention (baseline) 2) post-intervention (7 weeks), and 3) post intervention (13 weeks).

Couples Prostate Cancer Support Group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Men who have been treated for localized prostate cancer
  • AND men must be 6-36 months post-prostatectomy or radiation (as primary treatment) of prostate cancer
  • Must have a heterosexual, co-cohabiting partner who is willing to participate
  • Must speak and read English
  • Must be able to use a computer and have internet access

You may not qualify if:

  • Homosexual couples will not be included in this study
  • Major self-reported psychiatric illness
  • Couples who screen below 30 on the DAS (Dyadic Adjustment Scale)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Capital District

Halifax, Nova Scotia, Canada

Location

MeSH Terms

Conditions

Prostatic Neoplasms

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital Diseases

Study Officials

  • Deborah L McLeod, R.N., Ph.D.

    Capital District Health Authority & Dalhousie University

    PRINCIPAL INVESTIGATOR
  • Richard J Wassersug, Ph.D.

    University of British Columbia

    PRINCIPAL INVESTIGATOR
  • Karen Fergus, Ph.D., C. Psych.

    Sunnybrook Odette Cancer Centre & York University

    PRINCIPAL INVESTIGATOR
  • John Robinson, Ph.D., C. Psych.

    Tom Baker Cancer Centre & University of Calgary

    PRINCIPAL INVESTIGATOR
  • John Oliffe, R.N, Ph.D.

    University of British Columbia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 16, 2012

First Posted

October 30, 2012

Study Start

July 9, 2012

Primary Completion

October 31, 2016

Study Completion

October 31, 2016

Last Updated

August 21, 2024

Record last verified: 2014-03

Locations